Clinicopathological characteristics and outcomes of ROS1-rearranged patients with lung adenocarcinoma without EGFR, KRAS mutations and ALK rearrangements

BACKGROUND: c-ros oncogene 1 (ROS1) rearrangement presents one of the newest molecular targets in non-small cell lung cancer (NSCLC). ROS1 rearrangement is predominantly found in adenocarcinoma cases and is exclusive to other oncogenes, such as epidermal growth factor receptor (EGFR), Kirsten rat sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shafei, Wang, Jinghui, Zhou, Lijuan, Su, Dan, Liu, Yuanyuan, Liang, Xiaolong, Zhang, Shucai, Zeng, Xuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511318/
https://www.ncbi.nlm.nih.gov/pubmed/26273395
http://dx.doi.org/10.1111/1759-7714.12191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4511318/
https://www.ncbi.nlm.nih.gov/pubmed/26273395
http://dx.doi.org/10.1111/1759-7714.12191

Ejemplares similares